PhotoPharmics
Developer of non-invasive therapies designed to improve the lives of patients suffering from neurological disorders and addictions. The company's therapies offer chrono-biological treatments for Parki...
Valuation
$50M
Latest known
Share Price
N/A
Total Raised
$50.9M
Last Round
N/A